COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis

Bohdana Doskaliuk1, Roman Yatsyshyn2, Iryna Klishch3

  • 1Academician Ye. M. Neiko Department of Internal Medicine #1, Clinical Immunology and Allergology, Ivano-Frankivsk National Medical University, Halytska str. 2, Ivano-Frankivsk, 76000, Ukraine. Doskaliuk_Bo@ifnmu.edu.ua.

Insights

This bibliometric analysis reveals key trends in COVID-19 research within rheumatology, highlighting the most impactful studies and emerging topics. It offers insights into the global scientific response to the pandemic in rheumatic diseases.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Bibliometrics

Background:

  • The COVID-19 pandemic significantly impacted global health systems and rheumatology services.
  • Understanding the research landscape is crucial for adapting to new challenges.

Purpose of the Study:

  • To conduct a bibliometric and altmetric analysis of COVID-19 related articles in rheumatology.
  • To identify emerging topics and trends in this research area.

Main Methods:

  • Literature search on Scopus using specific keywords related to rheumatology and COVID-19.
  • Analysis of article types, authorship, journals, citations, countries, and keywords.
  • Visualization of author and keyword networks using VOSviewer.
  • Assessment of social impact using Altmetric data.

Main Results:

  • 1430 open-access articles were analyzed, primarily from the USA, Italy, and the UK.
  • Annals of the Rheumatic Diseases and Rheumatology International were top journals.
  • Clinical course of COVID-19 in patients with rheumatic diseases, particularly rheumatoid arthritis and systemic lupus erythematosus, received the highest citations.
  • A moderate correlation was found between Altmetric and citation scores.

Conclusions:

  • The study provides a comprehensive overview of COVID-19 research in rheumatology.
  • It highlights the most discussed rheumatic diseases and influential publications during the pandemic.
  • Findings offer insights into the adaptation of rheumatology services during the global health crisis.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
122
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
99
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
60
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
67